Cargando…
Identification of influenza A nucleoprotein body domain residues essential for viral RNA expression expose antiviral target
BACKGROUND: Influenza A virus is controlled with yearly vaccination while emerging global pandemics are kept at bay with antiviral medications. Unfortunately, influenza A viruses have emerged resistance to approved influenza antivirals. Accordingly, there is an urgent need for novel antivirals to co...
Autores principales: | Davis, Alicia M., Ramirez, Jose, Newcomb, Laura L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294902/ https://www.ncbi.nlm.nih.gov/pubmed/28173821 http://dx.doi.org/10.1186/s12985-017-0694-8 |
Ejemplares similares
-
Identification of influenza A nucleoprotein as an antiviral target
por: Kao, Richard Y, et al.
Publicado: (2010) -
The Antiviral Mechanism of an Influenza A Virus Nucleoprotein-Specific Single-Domain Antibody Fragment
por: Hanke, Leo, et al.
Publicado: (2016) -
Emerging antiviral resistant strains of influenza A and the potential therapeutic targets within the viral ribonucleoprotein (vRNP) complex
por: Davis, Alicia M, et al.
Publicado: (2014) -
Genetic variations on 31 and 450 residues of influenza A nucleoprotein affect viral replication and translation
por: Hung, Su-Jhen, et al.
Publicado: (2020) -
Nuclear localized Influenza nucleoprotein N-terminal deletion mutant is deficient in functional vRNP formation
por: Sanchez, Abel, et al.
Publicado: (2014)